The committed oligodendrocyte precursor cell, a newly‐defined intermediate progenitor cell type in oligodendroglial lineage
Glia · 2023-11 · 71 (11) · 2499-2510
DOI: 10.1002/glia.24426 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Glia, online erschienen am 06.06.2023. Verfasst von Minxi Fang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Key Laboratory of Organ Development and Regeneration, Institute of Life Sciences, College of Life and Environmental Sciences, Hangzhou Norma…. Hauptthemen laut MEDLINE: Demyelinating Diseases, Oligodendrocyte Precursor Cells. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 92 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
In the central nervous system, oligodendrocytes (OLs) produce myelin sheaths that provide trophic support to neuronal axons and increase the propagation speed of action potential. OLs are constantly generated from OL precursor cells (OPCs) throughout life span. The production of myelinating OLs consists of three canonical stages: OPCs, newly‐formed OLs (NFOs), and mature myelinating OLs. Recently, single‐cell RNA transcriptomic analyses identified a new population of oligodendroglial cells, namely differentiation committed OPCs (COPs). COPs represent a critical intermediate population between OPCs and NFOs, as revealed by specific expression of G‐protein coupled receptor 17 (GPR17). The dysregulation of COPs leads to the remyelination failure in demyelinating diseases and impairs the replacement of lost myelin sheaths due to aging. Hence, understanding the development of COPs and their underlying regulatory network will be helpful in establishing new strategies for promoting myelin repair in demyelinating diseases. This review summarizes the current knowledge on the development and functions of COPs under both physiological and pathological conditions. Overall, COPs function as “checkpoints” to prevent inappropriate precocious OL differentiation and myelination through expressing distinct regulatory factors. Deepening our understanding of COPs may not only advance our knowledge of how OL lineage progresses during development, but also open the door to new treatments for demyelinating diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhejiang Key Laboratory of Organ Development and Regeneration, Institute of Life Sciences, College of Life and Environmental Sciences, Hangzhou Normal University, Hangzhou, China.
- College of Life Sciences, Zhejiang University, Hangzhou, China.
- Department of Anatomy, Cell Biology & Physiology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- School of Basic Medical Science, Hangzhou Normal University, Hangzhou, China.
ORCID-Profile: Xiaofeng Xu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Fang, M., Chen, L., Tang, T., Qiu, M., & Xu, X. (2023). The committed oligodendrocyte precursor cell, a newly‐defined intermediate progenitor cell type in oligodendroglial lineage. Glia, 71(11), 2499-2510. https://doi.org/10.1002/glia.24426
Vancouver
Fang M, Chen L, Tang T, Qiu M, Xu X. The committed oligodendrocyte precursor cell, a newly‐defined intermediate progenitor cell type in oligodendroglial lineage. Glia. 2023;71(11):2499-2510. doi:10.1002/glia.24426
BibTeX
@article{Fang2023,
author = {Fang, Minxi and Chen, Lixia and Tang, Tao and Qiu, Mengsheng and Xu, Xiaofeng},
title = {The committed oligodendrocyte precursor cell, a newly‐defined intermediate progenitor cell type in oligodendroglial lineage},
journal = {Glia},
year = {2023},
volume = {71},
number = {11},
pages = {2499--2510},
doi = {10.1002/glia.24426}
}
EUVIMED